Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT01273610||Active, not recruiting||Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer||
||Other / Industry||
||40||All||60 Years and older (Adult, Older Adult)||NCT01273610||10112
|April 2011||June 2019||June 2019||January 10, 2011||August 16, 2018||